Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 2;26(1):222.
doi: 10.1186/s12882-025-04148-6.

The impact of Hemodiafiltration with endogenous reinfusion (HFR) on micronutrient status in patients undergoing maintenance hemodialysis: study protocol of a randomized controlled trial

Changhao Zhu #  1 , Lingling Ding #  1 , Naiying Lan #  1 , Fanzhou Zeng  1 , Dan Ye  1 , Hao Wang  2 , Bo Yang  3
Affiliations

The impact of Hemodiafiltration with endogenous reinfusion (HFR) on micronutrient status in patients undergoing maintenance hemodialysis: study protocol of a randomized controlled trial

Changhao Zhu et al. BMC Nephrol. .

Abstract

Background: End-stage renal disease (ESRD) is associated with significant morbidity and mortality, with patients often experiencing micronutrient deficiencies due to dialysis treatments. Hemodiafiltration with Endogenous Reinfusion (HFR) is a novel dialysis modality that combines diffusion, convection, and adsorption mechanisms to remove uremic toxins while potentially preserving essential nutrients. This study aims to assess the impact of HFR on micronutrient levels and removal rates in patients undergoing maintenance hemodialysis (HD).

Methods: This is a single-center, open-label, randomized controlled trial. Adult patients on maintenance HD will be randomized to two treatment arms: Arm A (Hemodiafiltration (HDF) followed by HFR) and Arm B (HFR followed by HDF), with a two-week washout period between treatments. Blood samples will be collected pre- and post-treatment to measure trace elements, water-soluble vitamins, and fat-soluble vitamins. Statistical analyses will include paired t-tests and Wilcoxon signed-rank tests for within-group comparisons, and repeated measures ANOVA for between-group differences, adjusting for potential confounders.

Discussion: This study will evaluate whether HFR offers superior retention of micronutrients compared to traditional HDF therapies, which may contribute to improved clinical outcomes for ESRD patients. Findings could provide valuable insights into the role of HFR in optimizing nutritional status and reducing dialysis-related complications. The cross-over design minimizes patient variability, enhancing the reliability of comparisons between treatment modalities.

Trial registration: This trial is registered with the Chinese Clinical Trial Registry (ChiCTR2500096698).

Keywords: Hemodiafiltration; Hemodiafiltration with endogenous reinfusion; Micronutrient; Randomized controlled trial.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study proposal was approved by the institutional review committee of the Naval Medical Center of PLA (registration number: 2024123104). The study will be conducted in accordance with the local legislation and institutional requirements. All participants will provide written consent. The consent form will be collected by Dan Ye. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Study flowchart
Fig. 2
Fig. 2
Schedule of enrolment, interventions, and assessments
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global epidemiology of End-Stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52:98–107. - PMC - PubMed
    1. Fleming GM. Renal replacement therapy review. Organogenesis. 2011;7:2–12. - PMC - PubMed
    1. Flythe JE. Dialysis-Past, present, and future: A Kidney360 perspectives series. Kidney360. 2023;4:567–8. - PMC - PubMed
    1. CROSS J. Does online hemodiafiltration lead to reduction in trace elements and vitamins? Hemodial Int. 2011;15:509–14. - PubMed
    1. Berger MM, Broman M, Forni L, Ostermann M, De Waele E, Wischmeyer PE. Nutrients and micronutrients at risk during renal replacement therapy: a scoping review. Curr Opin Crit Care. 2021;27:367–77. - PMC - PubMed

Publication types

LinkOut - more resources